These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31938931)

  • 21. Novel Heterozygous Mutations of NR5A1 and Their Functional Characteristics in Patients with 46,XY Disorders of Sex Development without Adrenal Insufficiency.
    Woo KH; Cheon B; Kim JH; Cho J; Kim GH; Yoo HW; Choi JH
    Horm Res Paediatr; 2015; 84(2):116-23. PubMed ID: 26139438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wide spectrum of NR5A1-related phenotypes in 46,XY and 46,XX individuals.
    Domenice S; Machado AZ; Ferreira FM; Ferraz-de-Souza B; Lerario AM; Lin L; Nishi MY; Gomes NL; da Silva TE; Silva RB; Correa RV; Montenegro LR; Narciso A; Costa EM; Achermann JC; Mendonca BB
    Birth Defects Res C Embryo Today; 2016 Dec; 108(4):309-320. PubMed ID: 28033660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening and familial characterization of copy-number variations in NR5A1 in 46,XY disorders of sex development and premature ovarian failure.
    Harrison SM; Campbell IM; Keays M; Granberg CF; Villanueva C; Tannin G; Zinn AR; Castrillon DH; Shaw CA; Stankiewicz P; Baker LA
    Am J Med Genet A; 2013 Oct; 161A(10):2487-94. PubMed ID: 23918653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ten novel mutations in the NR5A1 gene cause disordered sex development in 46,XY and ovarian insufficiency in 46,XX individuals.
    Camats N; Pandey AV; Fernández-Cancio M; Andaluz P; Janner M; Torán N; Moreno F; Bereket A; Akcay T; García-García E; Muñoz MT; Gracia R; Nistal M; Castaño L; Mullis PE; Carrascosa A; Audí L; Flück CE
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1294-306. PubMed ID: 22549935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New NR5A1 mutations and phenotypic variations of gonadal dysgenesis.
    Werner R; Mönig I; Lünstedt R; Wünsch L; Thorns C; Reiz B; Krause A; Schwab KO; Binder G; Holterhus PM; Hiort O
    PLoS One; 2017; 12(5):e0176720. PubMed ID: 28459839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 46,XY disorder of sex development and developmental delay associated with a novel 9q33.3 microdeletion encompassing NR5A1.
    Brandt T; Blanchard L; Desai K; Nimkarn S; Cohen N; Edelmann L; Mehta L
    Eur J Med Genet; 2013 Nov; 56(11):619-23. PubMed ID: 24056159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel NR5A1 variant in an infant with elevated testosterone from an Australasian cohort of 46,XY patients with disorders of sex development.
    Wu JY; McGown IN; Lin L; Achermann JC; Harris M; Cowley DM; Aftimos S; Neville KA; Choong CS; Cotterill AM
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):545-50. PubMed ID: 22909003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The spectrum of phenotypes associated with mutations in steroidogenic factor 1 (SF-1, NR5A1, Ad4BP) includes severe penoscrotal hypospadias in 46,XY males without adrenal insufficiency.
    Köhler B; Lin L; Mazen I; Cetindag C; Biebermann H; Akkurt I; Rossi R; Hiort O; Grüters A; Achermann JC
    Eur J Endocrinol; 2009 Aug; 161(2):237-42. PubMed ID: 19439508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutant NR5A1/SF-1 in patients with disorders of sex development shows defective activation of the SOX9 TESCO enhancer.
    Sreenivasan R; Ludbrook L; Fisher B; Declosmenil F; Knower KC; Croft B; Bird AD; Ryan J; Bashamboo A; Sinclair AH; Koopman P; McElreavey K; Poulat F; Harley VR
    Hum Mutat; 2018 Dec; 39(12):1861-1874. PubMed ID: 30067310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetic analysis of 46,XY disorders of sex development in children caused by a new NR5A1 gene variant].
    Gao L; Wang P; Zhang M; Qian Y; Liu N; Xu X; Wang X; Shu J; Lyu L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Nov; 38(11):1123-1126. PubMed ID: 34729757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional characterization of five NR5A1 gene mutations found in patients with 46,XY disorders of sex development.
    Fabbri-Scallet H; de Mello MP; Guerra-Júnior G; Maciel-Guerra AT; de Andrade JGR; de Queiroz CMC; Monlleó IL; Struve D; Hiort O; Werner R
    Hum Mutat; 2018 Jan; 39(1):114-123. PubMed ID: 29027717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a novel homozygous
    Kırkgöz T; Gürsoy S; Acar S; Köprülü Ö; Özkaya B; Arslan G; Nalbantoğlu Ö; Hazan F; Özkan B
    J Pediatr Endocrinol Metab; 2024 Jun; 37(6):575-579. PubMed ID: 38650427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The genetic spectrum of a Chinese series of patients with 46, XY disorders of the sex development.
    Zhang W; Mao J; Wang X; Zhao Z; Zhang X; Sun B; Cao Y; Nie M; Wu X
    Andrology; 2024 Jan; 12(1):98-108. PubMed ID: 37147882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application and insights of targeted next-generation sequencing in a large cohort of 46,XY disorders of sex development in Chinese.
    Chen H; Chen G; Li F; Huang Y; Zhu L; Zhao Y; Jiang Z; Yan X; Yu L
    Biol Sex Differ; 2024 Sep; 15(1):73. PubMed ID: 39285472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Five novel mutations in steroidogenic factor 1 (SF1, NR5A1) in 46,XY patients with severe underandrogenization but without adrenal insufficiency.
    Köhler B; Lin L; Ferraz-de-Souza B; Wieacker P; Heidemann P; Schröder V; Biebermann H; Schnabel D; Grüters A; Achermann JC
    Hum Mutat; 2008 Jan; 29(1):59-64. PubMed ID: 17694559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function.
    Lin L; Philibert P; Ferraz-de-Souza B; Kelberman D; Homfray T; Albanese A; Molini V; Sebire NJ; Einaudi S; Conway GS; Hughes IA; Jameson JL; Sultan C; Dattani MT; Achermann JC
    J Clin Endocrinol Metab; 2007 Mar; 92(3):991-9. PubMed ID: 17200175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Four Novel NR5A1 Mutations in 46,XY Gonadal Dysgenesis Patients Including Frameshift Mutations with Altered Subcellular SF-1 Localization.
    Rehkämper J; Tewes AC; Horvath J; Scherer G; Wieacker P; Ledig S
    Sex Dev; 2017; 11(5-6):248-253. PubMed ID: 29190620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic reanalysis of patients with a difference of sex development carrying the NR5A1/SF-1 variant p.Gly146Ala has discovered other likely disease-causing variations.
    Martinez de Lapiscina I; Kouri C; Aurrekoetxea J; Sanchez M; Naamneh Elzenaty R; Sauter KS; Camats N; Grau G; Rica I; Rodriguez A; Vela A; Cortazar A; Alonso-Cerezo MC; Bahillo P; Bertholt L; Esteva I; Castaño L; Flück CE
    PLoS One; 2023; 18(7):e0287515. PubMed ID: 37432935
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Naamneh Elzenaty R; Kouri C; Martinez de Lapiscina I; Sauter KS; Moreno F; Camats-Tarruella N; Flück CE
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preserved fertility in a patient with a 46,XY disorder of sex development due to a new heterozygous mutation in the NR5A1/SF-1 gene: evidence of 46,XY and 46,XX gonadal dysgenesis phenotype variability in multiple members of an affected kindred.
    Ciaccio M; Costanzo M; Guercio G; De Dona V; Marino R; Ramirez PC; Galeano J; Warman DM; Berensztein E; Saraco N; Baquedano MS; Chaler E; Maceiras M; Lazzatti JM; Rivarola MA; Belgorosky A
    Horm Res Paediatr; 2012; 78(2):119-26. PubMed ID: 22907560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.